BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| fructo-oligosaccharides - Bifidobacterium faecale |
👶
Fructooligosaccharide (FOS) and Galactooligosaccharide (GOS) Increase Bifidobacterium but Reduce Butyrate Producing Bacteria with Adverse Glycemic Metabolism in healthy young population. Scientific reports (Sci Rep ) Vol: 7 Issue 1 Pages: 11789 Pub: 2017 Sep 18 Epub: 2017 Sep 18 Authors Liu F , Li P , Chen M , Luo Y , Prabhakar M , Zheng H , He Y , Qi Q , Long H , Zhang Y , Sheng H , Zhou H , Html Article Publication |
| fructo-oligosaccharides - Bifidobacterium faecale |
👶
Oligofructose as an adjunct in treatment of diabetes in NOD mice. Scientific reports (Sci Rep ) Vol: 6 Issue Pages: 37627 Pub: 2016 Nov 22 Epub: 2016 Nov 22 Authors Chan C , Hyslop CM , Shrivastava V , Ochoa A , Reimer RA , Huang C , Html Article Publication |
| fructo-oligosaccharides - Bifidobacterium faecale |
👶
Chemically defined diet alters the protective properties of fructo-oligosaccharides and isomalto-oligosaccharides in HLA-B27 transgenic rats. PloS one (PLoS One ) Vol: 9 Issue 11 Pages: e111717 Pub: 2014 Epub: 2014 Nov 4 Authors Koleva P , Ketabi A , Valcheva R , Gänzle MG , Dieleman LA , Html Article Publication |
| fructo-oligosaccharides - Bifidobacterium faecale |
👶
Fructooligosaccharides (FOS) differentially modifies the in vitro gut microbiota in an age-dependent manner. Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 1058910 Pub: 2022 Epub: 2023 Jan 12 Authors Mahalak KK , Firrman J , Narrowe AB , Hu W , Jones SM , Bittinger K , Moustafa AM , Liu L , Html Article Publication |
| fructo-oligosaccharides - Bifidobacterium faecale |
👶
Effect of Fructooligosaccharides Supplementation on the Gut Microbiota in Human: A Systematic Review and Meta-Analysis. Nutrients (Nutrients ) Vol: 14 Issue 16 Pages: Pub: 2022 Aug 12 Epub: 2022 Aug 12 Authors Dou Y , Yu X , Luo Y , Chen B , Ma D , Zhu J , Html Article Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
